Jan Pot

Focus

Complex disputes involving IP, technology, privacy and competition law.

Client work

Jan Pot is an experienced litigator who focuses on complex, high-impact disputes at the intersection of law, technology and policy. He acts for leading tech companies, platforms and innovation-driven businesses in litigation involving digital regulation, competition law and IP. His practice spans collective actions, mass claims, private enforcement disputes and follow-on claims. He has litigated cases involving the GDPR, DSA and DMA. These matters require a multidisciplinary approach and the ability to translate complex technical issues into clear, persuasive courtroom arguments.

Jan is also an accomplished patent litigator and registered UPC representative. His patent litigation experience covers biologics, small-molecule pharmaceuticals, medical devices and standard-essential patents. He has acted in numerous cross-border cases. This experience makes him well placed to help clients navigate the European patent litigation landscape as it undergoes fundamental change.

Clients praise Jan for his breadth of expertise, strategic approach and courtroom advocacy skills, as well as his ability to quickly grasp complex technologies. This combination makes him a go-to adviser for clients facing sophisticated, multidimensional claims.

Expertise

• Complex, high-impact tech litigation
• Private enforcement disputes involving digital regulation and competition law
• Mass claims and collective actions under the Dutch WAMCA regime
• Patent litigation and UPC representation

Background

Jan focuses on contentious work for innovation-driven clients in the technology, platform and life sciences sectors. He remains active in patent litigation and is a registered UPC representative.

Jan was admitted to the bar of the Supreme Court of the Netherlands in 2019. He is one of only a few Supreme Court advocates in the Netherlands specialising in technology and IP.

Before being admitted to the bar, Jan spent several years as an external court clerk at the Amsterdam District Court. He studied law at the University of Amsterdam and Columbia Law School.

Recognition

Jan is known for combining sharp litigation skills with a deep understanding of technology and intellectual property. This enables him to navigate complex technical evidence while maintaining a clear focus on procedural strategy and commercial outcomes. His work on WAMCA collective actions, follow-on damages claims and patent litigation demonstrates his ability to manage matters where legal risk, reputational impact and technical complexity intersect.

Legal 500 2025 client feedback includes:

“Specific mention goes to Jan Pot, who is a particularly great litigator. He is intelligent, strategic, persuasive and well versed in the complexities of the law and the courtroom.”

“Jan Pot is an exceptional partner. He has such detailed knowledge of both procedure and substantive law. He provides the expertise that sophisticated companies need. I always learn something from him and he always takes less time to do something than anticipated.”

Chambers 2021 reported ‘glowing client praise, with one calling him "experienced beyond his years," while another reports that he is "hugely hard-working" and "very good with the clients."'

Selected experience

• Technology, platform litigation and class actions
• Representation of X Corp. (formerly Twitter) in class action proceedings brought by Data Justice Europe (formerly SDBN) concerning alleged GDPR and DSA violations.
• Representation of a leading technology company in class action proceedings and follow-on damages claims concerning alleged violations of European competition law.
• Representation of a European advertising technology company in disputes concerning GDPR compliance.

IP, patent and UPC litigation

• Representation of Celltrion in biologics and biosimilar litigation against Roche concerning patents relating to Mabthera® (rituximab).
• Representation of Synthon in proceedings against Teva concerning the validity of several patent families relating to Copaxone® (glatiramer acetate), successfully clearing the way for Synthon’s glatiramer acetate product.
• Representation of ZTE in proceedings brought by a patent assertion entity concerning standard-essential patents.
• Representation of Infineon in Supreme Court proceedings concerning alleged infringement of trademarks for NFC chips.